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Summary
. In 2016, 55 of 62 centres in England, Wales and
Northern Ireland returned data on ﬁrst access for
4,564 incident haemodialysis (HD) and 1,246 inci-
dent PD recipients.
. Of these 5,810 incident patients, 50% started dialysis
with deﬁnitive access: 21.5% started PD, 28.5%
started HD with an arteriovenous ﬁstula (AVF) or
graft (AVG), 28.4% with a tunnelled line (TL) and
21.7% with a non-tunnelled line (NTL).
. Wide variation in deﬁnitive access use (deﬁned as
primary AVF, AVG or PD) was apparent between
centres.
. Sixteen centres achieved the 60% target for AVF/
AVG use amongst incident HD recipients.
. Seventeen centres achieved the 80% target for AVF/
AVG/PD use amongst prevalent dialysis recipients.
. Timely presentation to a nephrologist and referral to
a dialysis access surgeon remained key determinants
of the likelihood of deﬁnitive access at dialysis
initiation
. For late-presenting patients, deﬁnitive access 90
days after initiating dialysis ranged between 42.9%
and 0.0% by centre, implying variation in the
responsiveness of dialysis access pathways.
. For centres returning data on one-year PD access
outcomes, 70.7% of patients starting PD continued
to use this modality or have been transplanted one
year later.
. The mean one-year PD catheter failure rate was
18.4%.
. This report demonstrates wide variation in practice
between centres across several domains in the
provision of dialysis access.
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Introduction
Provision of deﬁnitive dialysis access is an important
measure of good clinical care for patients with established
renal failure. Relevant recommendations and audit
standards are presented in the Renal Association clinical
practice guidelines (table 10.1). The annual multisite
dialysis access audit provides centre-level information
on access provision in England, Wales and Northern
Ireland. Although the Renal Association undertook a
national vascular access audit in 2005, published with
outcomes data in 2012 by the UK Renal Registry
(UKRR) [1], this is the sixth annual audit that combines
peritoneal and vascular access, presenting information
for patients starting dialysis between 1 January and
31 December 2016. The objective of this audit is to
highlight centre-level performance variation and explore
factors that may contribute to the provision of high
quality vascular and peritoneal access.
The term ‘established renal failure’ used within this
chapter is synonymous with the terms ‘end stage renal
failure’ and ‘end stage kidney disease’. These alternative
terms are in widespread international use, but are less
acceptable to patients.
Methods
In 2017, all adult renal centres in England, Wales and Northern
Ireland were asked to provide vascular and peritoneal access data
for incident (1 January to 31 December 2016) and prevalent
dialysis patients. Access data for incident patients were collected
at patient level, whereas centre-level data were submitted for
prevalent patients. Table 10.2 presents a full glossary of collected
variables. Data were collected using Microsoft Excel spreadsheets
circulated by the UKRR.
Records were validated against the UKRR database to conﬁrm
that the population collected at each centre for the audit was the
same as, or representative of, the incident population at that centre
collected via the routine quarterly return. Data checks were made
by cross-referencing with the UKRR database. Any patients identi-
ﬁed from the UKRR as not incident to dialysis between 1 January
2016 and 31 December 2016 were excluded. For the purposes of
this audit, patients were categorised as having acute kidney injury
(AKI) if their access at three months was recorded as ‘recovered
renal function’ and were therefore excluded from analysis. Patients
Table 10.1. Summary of relevant audit standards stated in the Renal Association clinical practice guidelines
RA audit measure/guideline∗ Reported Notes
1 Proportion of planned renal replacement therapy initiations with established access or
pre-emptive transplantation (no minimum audit standard)
Yes Table 10.3
Table 10.4
Table 10.9
Table 10.10
2 60% of all incident patients with established end stage kidney disease commencing
planned haemodialysis should receive dialysis via a functioning arteriovenous ﬁstula or
arteriovenous graft
Yes Table 10.3
Table 10.4
Table 10.9
Table 10.10
Figure 10.5
3 80% of all prevalent long-term dialysis patients should receive dialysis treatment via
‘deﬁnitive access’: arteriovenous ﬁstula, arteriovenous graft or peritoneal dialysis
Yes Figure 10.7
Table 10.10
4 Peritoneal dialysis catheter patency – more than 80% of catheters should be patent at one
year (censoring for death and elective modality change)
Partly Figure 10.13
Figure 10.15
5 Complications following peritoneal dialysis catheter insertion: Partly Figure 10.14
Figure 10.15
5a Bowel perforation ,1% No Not captured by
the audit
5b Signiﬁcant haemorrhage ,1% No Not captured by
the audit
5c Exit site infection within two weeks of catheter insertion ,5% No Not captured by
the audit
5d Peritonitis within two weeks of catheter insertion ,5% Yes Figure 10.13
∗Audit standards from the most recent Renal Association guidelines (June 2017) are presented. Current and previous guidelines are available
on the Renal Association website (www.renal.org/guidelines/current-guidelines)
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Table 10.2. Glossary of variables collected in the 2016 Multisite Dialysis Access Audit
Audit data item Deﬁnition [format] PD/HD or both
ID Local hospital number [numerical] Both
NHS number NHS number (England & Wales) [numerical] Both
Surname [text] Both
Forename [text] Both
DoB Date of birth [DD/MM/YY] Both
Sex [Male/Female/Unknown] Both
Date of death [DD/MM/YY] Both
Postcode The postcode of the patient’s usual address [alpha-numerical] Both
First RRT treatment centre code Renal treatment centre where ﬁrst dialysis took place
[treatment centre ID code]
Both
Primary renal diagnosis Primary renal diagnosis [EDTA four digit diagnosis code] Both
BMI BMI at time of access insertion (weight in kg/height in m2)
[numerical]
Both
Date ﬁrst seen by renal physician The date the patient was ﬁrst seen by a renal physician (as an
outpatient or inpatient) [DD/MM/YY]
Both
Assessed by surgeon for an AVF, AVG or PD
catheter at least three months before dialysis?
Was the patient assessed by a surgeon regarding dialysis
access at least three months before their ﬁrst dialysis date?
[Yes/No]
Both
Was an AVF/AVG attempted before 1st dialysis? Was an AVF/AVG attempted before the ﬁrst ever dialysis
session? [Yes/No/Unknown]
Both
Date FIRST EVER dialysis session Date of ﬁrst ever dialysis session [DD/MM/YY] Both
First ever modality First ever renal replacement modality [HD/PD] Both
Access in use at ﬁrst ever dialysis Dialysis access in use at ﬁrst dialysis (may not be ﬁrst access
created) [AVF/AVG/vein loop/TL/NTL/PD/temporary PD
catheter]
Both
Access in use at three months Dialysis access in use three months after the start of ﬁrst
treatment [AVF/AVG/vein loop/TL/NTL/PD/temporary PD
catheter/recovered/transplant/conservative/death/lost to
follow-up/transferred out]
Both
Same access in use 3 months later Same actual access in use at ﬁrst dialysis and 3 months i.e.
same catheter, same AVF; same AVG) [Yes/No]
Both
Date of ﬁrst ever access insertion/construction Date of creation/insertion of ﬁrst ever dialysis access (if
Moncrief PD catheter, date of externalisation) [DD/MM/YY]
Both
Diabetes at time of access creation Does the patient have diabetes mellitus (type 1 or 2) at time
of dialysis access creation? [Yes/No]
Both
PD catheter insertion technique Technique used to insert PD catheter [open /laparoscopic/
percutaneous]
PD only
Peritonitis episode Peritonitis episode within two weeks of insertion? [Yes/No] PD only
Access complication Reason for access failure/discontinuation [selection from
27 item list]
Both
Date of access failure/discontinuation Date access is no longer usable for treatment [DD/MM/YY] Both
Comments Any relevant comments [text] Both
RRT – renal replacement therapy; BMI – body mass index; HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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with missing information for access at start, age and date of
starting renal replacement therapy (RRT) were excluded from
the analysis. Patients were excluded when there was no matching
record in the UKRR database (patient assumed to be AKI) and
when aged ,18 years. If a centre reported prevalent numbers
that differed by more than 10% from those in the UKRR database,
it was excluded. Cross-referencing also enabled ascertainment of
mortality within three months of commencing dialysis.
Patients starting haemodialysis were grouped by type of ﬁrst
vascular access: arteriovenous ﬁstula, arteriovenous graft, tun-
nelled dialysis line, non-tunnelled dialysis line. Patients starting
peritoneal dialysis were categorised by the insertion technique:
open surgery, laparoscopic, peritoneoscopic or percutaneous.
Access at three months was deﬁned as the type of access in use
at three months after starting dialysis. If a patient was no longer
receiving dialysis at three months (but had not recovered renal
function), the reason was recorded instead, for example, ‘death’
or ‘transplantation’. Referral time was deﬁned as the number of
days between the date of ﬁrst being seen by a renal physician (as
an inpatient or outpatient) and the date of commencing dialysis.
A patient was classiﬁed as presenting ‘late’ if they had a referral
time of less than 90 days.
Access failure was deﬁned when it was no longer usable for
dialysis with the date and cause of access failure reported. For
the purposes of analysis, HD access failure was grouped into ﬁve
causes: maturation, mechanical, infection, other and unknown.
PD technique failure was grouped into six causes: infection,
catheter related, solute/water clearance, leaks/hernia, other and
unknown. Access failure was censored for death, transplantation,
withdrawal from RRT and elective switching of access type. It
was the intention to only capture access failures relating to the
ﬁrst access that was performed. If the reason recorded for access
failure was not related to the ﬁrst type of access recorded, then
the data were not included in this analysis.
Centres that reported data on PD patients in the 2015 vascular
and peritoneal access audit were asked to complete a one year
follow-up of their PD patients. Additional information was
requested on the date of PD catheter failure, the reason for catheter
failure, the number of catheters used during the year and the
modality in use at one year after starting PD. Analyses that use
these data are titled ‘PD follow-up audit’.
As in the 19th Annual Report, this chapter includes data for
pre-emptive transplant (PTx) recipients. This reﬂects the amended
(2015) Renal Association guidelines for planned RRT initiation,
which include PTx in the audit standard (table 10.1). Where
possible, these data have been included at centre level to aid in
the interpretation of the effects of PTx upon rates of deﬁnitive
and non-deﬁnitive dialysis access. Transplant and non-transplant
centres work together to prepare patients for PTx, but for the
purpose of these analyses, patients have been allocated to their
most likely treatment centre (transplant or non-transplant)
using the approach of Judge et al. [2]; this is based on patient
postcode and the likelihood of receiving care in a centre.
Separate and combined analyses were performed for incident
HD and PD patients as appropriate. Analyses have been limited
to descriptive statistics of frequencies, percentages and unadjusted
associations between variables. All inter-centre performance com-
parisons are made in the context of varying patient demography,
case mix and volume. If a centre had .50% missing returns for
a particular data ﬁeld, then all patients from that centre were
excluded from analyses involving that data ﬁeld. The data were
analysed using SAS 9.3.
Results
Of 62 centres contacted, 55 returned data on ﬁrst
dialysis access used. After individual patient exclusions,
5,810 patients were included, comprising 4,564 starting
HD and 1,246 starting PD (ﬁgure 10.1, table 10.3).
UKRR 2016 incident data for centres submitting data
were 4,546 HD and 1,298 PD patients. The slight over-
reporting represents the inability to check all patients
against the UKRR dataset, because some centres did
not provide patient-level data. It is also possible that a
small number of patients with AKI remained in the
audit data because of incomplete data at three months.
Furthermore, it is possible that some patients who were
excluded because they did not match to the UKRR data-
base did not have AKI, but instead started dialysis
towards the end of 2016 and the UKRR had not yet
received that data from renal centres.
Total number of incident patients in 
Dialysis Access audit
7,145 (55 centres) 
Total number of incident dialysis 
patients included in analysis
5,810 (55 centres)
Total number of incident dialysis 
and pre-emptive transplant patients 
(475 pre-emptive transplants)
6,213 (54 centres)* 
Patient exclusions:
7 duplicate patients
619 patients did not match to the 
UKRR data
692 patients recovered by 3 months
3 patients did not have data for 
access at start
2 patients did not have data for 
RRT start
12 patients were aged <18 years
Fig. 10.1. STROBE ﬂow diagram of patients included in the 2016
Multisite Dialysis Access Audit
∗Cambridge excluded as patient level data for pre-emptive transplants in
2016 were not submitted to the UKRR
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Table 10.3. Demographics and characteristics of patients in the 2016 Multisite Dialysis Access Audit, stratiﬁed by ﬁrst dialysis
access type
HD patients PD patients
Variable N AVF/AVG TL NTL N
Open
surgery
Laparo-
scopic
Peritoneo-
scopic
Percuta-
neous Missing Total
Total number 4,564 1,658 1,648 1,258 1,246 404 291 30 410 111 5,810
Percentage 36.3 36.1 27.6 32.4 23.4 2.4 32.9 8.9
Age at ﬁrst
dialysis
Median
(IQR)
67
(55,76)
68
(56,77)
66
(54,75)
69
(55,78)
61
(47,72)
60
(47,71)
61
(49,71)
65
(50,75)
60
(46,72)
57
(44,69)
64
(51,74)
,45 523 27.2 43.6 29.3 268 32.8 20.1 34.3 791
45–54 608 37.7 37.3 25.0 225 32.4 24.0 3.1 32.4 8.0 833
55–64 932 38.3 37.6 24.1 250 33.6 24.8 29.2 1,182
65–74 1,204 37.0 35.9 27.2 297 30.0 27.3 2.7 32.3 7.7 1,501
75+ 1,297 37.4 31.7 30.9 206 34.0 19.4 3.9 36.9 5.8 1,503
BMI ,20 157 31.2 43.3 25.5 36 44.4 25.0 16.7 193
20–24 541 40.3 34.6 25.1 207 37.7 31.9 24.2 748
25–29 646 43.5 31.1 25.4 222 38.7 34.7 2.3 20.7 3.6 868
30–34 461 46.6 33.0 20.4 144 38.2 37.5 20.8 605
35+ 382 48.4 31.7 19.9 65 36.9 41.5 15.4 447
No data 742 23.7 29.9 46.4 130 30.8 14.6 46.9 872
PRD Diab 1,214 41.2 39.0 19.8 338 24.9 26.0 2.1 37.3 9.8 1,552
Glom 450 39.6 37.6 22.9 211 34.1 24.6 2.8 30.3 8.1 661
Hypert 282 47.9 30.9 21.3 89 28.1 16.9 44.9 371
Other 906 16.9 34.1 49.0 157 34.4 24.2 3.8 29.3 8.3 1,063
Polyc 208 63.0 26.4 10.6 88 47.7 28.4 19.3 296
Pyelo 245 41.2 35.9 22.9 60 31.7 28.3 31.7 305
RVD 280 40.7 30.0 29.3 74 41.9 12.2 33.8 354
Uncert 643 36.4 39.2 24.4 173 30.1 22.5 39.3 816
No PRD 166 24.7 43.4 31.9 17 35.3 29.4 183
Referral time
(days)
,90 1,116 3.0 38.9 58.2 82 31.7 19.5 35.4 1,198
90–180 202 24.3 56.9 18.8 83 34.9 19.3 32.5 285
180–365 341 37.5 41.3 21.1 116 28.4 27.6 31.0 457
365+ 2,789 51.0 32.7 16.3 952 32.5 23.6 2.4 33.1 8.4 3,741
No data 116 23.3 39.7 37.1 13 53.8 129
Assessed by
surgeon
Yes 2,010 72.9 21.6 5.5 514 34.8 28.0 1.0 25.1 11.1 2,524
No 2,379 6.1 48.0 45.9 616 30.7 20.0 4.1 43.0 2.3 2,995
No data 77 26.0 35.1 39.0 82 36.6 26.8 19.5 159
Sex Female 1,647 35.4 37.9 26.7 461 36.7 23.2 3.0 28.6 8.5 2,108
Male 2,917 36.9 35.1 28.0 785 29.9 23.4 2.0 35.4 9.2 3,702
Ethnicity Asian 520 33.5 43.7 22.9 160 21.9 19.4 48.1 680
Black 330 27.3 48.2 24.5 87 17.2 25.3 37.9 417
Other 129 31.0 43.4 25.6 54 37.0 18.5 29.6 183
White 3,265 38.1 33.1 28.9 893 35.3 23.4 2.9 30.6 7.8 4,158
No data 251 33.1 34.3 32.7 49 34.7 38.8 20.4 300
eGFR at
start
Median
(IQR)
7(5,9) 7(6,9) 7(5,9) 7(5,9) 7(6,10) 8(6,10) 7(6,9) 7(6,12) 7(6,9) 8(6,10) 7(6,10)
Diabetes Yes 1,686 41.7 35.8 22.5 405 28.4 27.7 2.5 37.3 4.2 2,091
No 2,164 35.7 34.1 30.3 684 36.4 24.1 2.9 33.3 3.2 2,848
No data 192 22.4 24.0 53.6 46 23.9 26.1 21.7 238
Centres with .50% missing data for a variable were excluded from summary data and analyses relating to that variable, hence the total number of
patients does not always sum to 5,810
Blank cells – ,5 patients, percentages not shown
IQR – interquartile range; BMI – body mass index; PRD – primary renal diagnosis; DM – diabetes mellitus; GN – glomerulonephritis; HTN –
hypertension; PKD – polycystic kidney disease; Pyelo – pyelonephritis; RVD – renal vascular disease; HD – haemodialysis; PD – peritoneal dialysis;
eGFR – estimated glomerular ﬁltration rate; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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Data completeness
Data completeness varied between 100% (date of birth,
sex, dialysis start date, ﬁrst dialysis access, ﬁrst dialysis
modality and access at three months) and 28.7% (date
of access failure). The data on diabetes were supple-
mented by triangulation with UKRR comorbidity and
primary renal diagnosis (PRD), increasing completeness
of diabetic status to 89.0%. Of 50 centres that reported
data on PD patients in 2015 (N = 1,075), 38
completed the one year follow-up, returning data on
902 patients.
Variations in ﬁrst dialysis access
The following observations can be made of incident
dialysis access. These represent associations and do not
imply causality. Data were unadjusted for patient factors.
. 50.0% of dialysis patients started therapy using
deﬁnitive access: AVF/AVG or a PD catheter.
. 36.3% of HD patients started therapy using an AVF
or AVG.
. AVF use increased with increasing referral time,
with corresponding reductions in TL/NTL use:
48.0% of incident HD patients known to a nephrol-
ogist for over 90 days had an AVF/AVG which was
below the Renal Association audit standard of 60%
(table 10.1).
. AVF use increased with increasing age and BMI,
with corresponding reductions in TL/NTL use.
. Percutaneous PD catheter placement was less
common at extremes of BMI.
. Use of deﬁnitive access was high (74.0%) for patients
with polycystic kidney disease listed as their PRD.
This has been a consistent ﬁnding in the audit, likely
to reﬂect factors associated with the disease –
including early diagnosis and referral, younger age,
a predictable clinical course and high health
literacy.
. For patients starting haemodialysis with ‘other’
listed as their PRD, AVF/AVG use was particularly
low (16.9%).
. Incident HD recipients who had been reviewed by a
surgeon at least three months prior to starting
dialysis had higher AVF/AVG use than those who
had not (72.9% vs 6.1%).
. Black patients starting HD had markedly lower rates
of AVF/AVG use (27.3%) compared to the average
(36.3%).
Figure series 10.2 assists interpretation of table 10.3
by including annual PTx data. Transplant data were
included to provide a more complete depiction of
incident RRT patterns. Data remain otherwise unad-
justed. For detailed analysis see chapters 3 and 9 of this
annual report. Data were plotted and stratiﬁed by age
(ﬁgure 10.2a), BMI (ﬁgure 10.2b), PRD (ﬁgure 10.2c),
referral time (ﬁgure 10.2d), diabetic status (ﬁgure 10.2e)
and surgical referral (ﬁgure 10.2f). Centres with .50%
missing data for a variable were excluded, as detailed in
the ﬁgure legend. BMI data on PTx recipients are not
presented due to low data returns, although it is recog-
nised that very few transplant recipients will have BMI
.35. Transplant data were not presented against surgical
referral data because all patients who received a PTx
will have received surgical review. HD and PD data are
displayed separately in ﬁgure 10.2f because the surgical
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Fig. 10.2a. Incident RRT approach for
patients in the 2016Multisite Dialysis Access
Audit, stratiﬁed by age
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL –
non-tunnelled line; RRT – renal replacement
therapy
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Fig. 10.2b. Incident RRT approach for
patients in the 2016Multisite Dialysis Access
Audit, stratiﬁed by BMI
Number of patients in each group in brackets.
17 centres were excluded due to .50% missing
BMI data
PD – peritoneal dialysis; AVF – arteriovenous
ﬁstula; AVG – arteriovenous graft; TL – tunnelled
line; NTL – non-tunnelled line; BMI – body mass
index; RRT – renal replacement therapy
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Fig. 10.2c. Incident RRT approach for
patients in the 2016Multisite Dialysis Access
Audit, stratiﬁed by PRD
Number of patients in each group in brackets.
PRD groups are sorted by decreasing proportion
of patients initiating RRT with a HD catheter
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL –
non-tunnelled line; RVD – reno-vascular disease;
DM – diabetes mellitus; Pyelo – pyelonephritis;
HTN – hypertension; GN – glomerulonephritis;
PKD – polycystic kidney disease; RRT – renal
replacement therapy
0  20  40  60  80  100
Percentage incident RRT patients
La
te
 p
re
se
nt
at
io
n 
gr
ou
p
<90
(N = 1,196)
90–180
(N = 289)
180–365
(N = 468)
365+
(N = 4,049)
Missing
(N = 211)
PTx
PD
AVF/AVG
TL
NTL
Fig. 10.2d. Incident RRT approach for
patients in the 2016Multisite Dialysis Access
Audit, stratiﬁed by referral time
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL –
non-tunnelled line; RRT – renal replacement
therapy
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pathways for vascular and PD access differ. Late present-
ing patients were excluded from this analysis. The follow-
ing observations can be made:
. Rising use of AVF/AVG with increasing age was
associated with falling rates of transplant and PD.
. Amongst incident RRT patients with BMI ,20, PD
use was low (18.7%) and TL/NTL use was high
(56.0%). Otherwise the rising use of AVF/AVG
with increasing BMI was associated with falling
rates of PD.
. PRD had a variable association with use of deﬁnitive
dialysis access and PTx. For example, for polycystic
kidney disease both deﬁnitive dialysis access (60.0%)
and PTx (19.6%) were common. Where PRD was
listed as ‘other’, deﬁnitive dialysis access (28.0%)
and PTx (5.2%) were both uncommon. In reno-
vascular disease deﬁnitive dialysis access was estab-
lished in 52.1% of incident patients, whilst PTx was
very rare (1.4%).
. Increasing referral time was associated with a pro-
gressive increase in PD, AVF/AVG and PTx use,
with corresponding reductions in use of TL/NTL.
This pattern continued as referral time increased
beyond 365 days for PTx and AVF/AVG.
. 64.5% of incident RRT patients known to a nephrol-
ogist for over 90 days had deﬁnitive access or a
transplant. Whilst the Renal Association presents
this as an audit standard, no minimum standard is
set (table 10.1).
No
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(N = 476)
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. PD was initiated for only 6.9% of late presentations
(people known to a nephrologist for less than
90 days).
. Patients with diabetes were more likely to use an
AVF/AVG and less likely to receive PTx or PD
than patients without diabetes, but use of TL/NTL
was similar.
. AVF/AVG use was much higher amongst haemo-
dialysis recipients referred to a surgeon .90 days
before dialysis initiation (73.5%) than those who
were not (9.9%).
Variations in ﬁrst dialysis access by renal centre
Figure 10.3 plots incident RRT ﬁrst access method
stratiﬁed by centre. Practice variation was apparent.
Initiating HD via an AVF/AVG ranged between ,15%
(Ipswich, London St Bartholomew’s, London West,
Ulster, Carlisle) and .40% (Chelmsford, Dorset, Mid-
dlesbrough). Initiating HD via a TL ranged between
,10% (Nottingham, Derby, Basildon, Newry) and
.45% (London West, Carlisle, Ipswich). Initiating with
a PD catheter ranged from ,10% (Truro, Sunderland,
Stevenage) to .40% (Derby). There is no obvious
difference in the pattern of ﬁrst RRT access method
used when comparing transplanting and non-transplant-
ing centres.
Table 10.4 provides centre-level data for incident
dialysis access, grouping patients by time of presentation
to nephrology (early590 or late,90 days before initiat-
ing dialysis). Late presentation was associated with low
rates of deﬁnitive access placement (9.6%). Peritoneal
catheter placement accounted for 71.3% of deﬁnitive
access placed in late presenting patients. Nineteen centres
reported no late presenting patients dialysing with
deﬁnitive access at initiation. Some centres were able to
establish deﬁnitive vascular access for late presenting
patients, although absolute numbers of patients were
small. Surgical referral was made 90 days or more before
dialysis initiation for 45.9% of incident patients, and
ranged between .70% (Birmingham QEH, Bangor,
Ipswich) and ,25% (Plymouth, Swansea, Carlisle).
Table 10.5 provides centre-level data for dialysis access
three months after initiation, grouping patients by time
of initial presentation to nephrology (early 590 or late
,90 days before initiating dialysis). Late presentation
remained associated with low rates of deﬁnitive access
use at three months (15.1%) compared with early presen-
tation (60.2%). TL was the mode of access for 59.6% of
late presenting patients at three months. Of early presen-
ters, 1.3% were transplanted by three months. Of late
presenting patients, 0.2% were transplanted by three
months. Ten centres had no late presenting patients dia-
lysing with deﬁnitive access at three months.
Figure 10.4 plots RRT approach at three months for
late presenting patients. Deﬁnitive access ranges between
42.9% and 0.0% by centre, implying variation in the
responsiveness of dialysis access pathways. Some centres
were able to establish deﬁnitive access in over 30% of late
presenting patients by three months, the majority of
whom started PD.
Table 10.6 shows dialysis access three months after
initiation, stratiﬁed by ﬁrst access type. The shaded cells
highlight proportions of patients who continued with
their initial dialysis access technique at three months.
This analysis reﬂects RRT approach at initiation and
three months, and therefore cannot identify access failure
unless this results in a change in access approach. See
ﬁgure 10.14 for failure of initial access. Of patients who
initiated dialysis with deﬁnitive access, 87.7% continued
with deﬁnitive access at three months and 89.4% had
deﬁnitive access or a transplant, whilst 5.8% converted
to TL/NTL. Of patients who started dialysis without
deﬁnitive access, 10.4% received a transplant or were
dialysing with deﬁnitive access at three months. Of
patients who initiated dialysis with a TL, 78.7% continued
with a TL at three months and only 11.0% had converted
to deﬁnitive access or a transplant. The majority of
patients who initiated dialysis with a NTL continued
HD via a TL (60.3%). Death before three months was
much more common in this group than any other
(25.2%).
Figure 10.5 provides a funnel plot of the percentage of
patients starting HD with an AVF or AVG. Late present-
ing patients are excluded as a surrogate for ‘unplanned
dialysis initiation’ as per the Renal Association guidelines
(table 10.1). This analysis shows that the majority of UK
renal centres fell below the Renal Association audit stan-
dard of560% AVF/AVG use at ‘planned’ HD initiation.
Sixteen centres achieved the target. Twelve centres were
below the 99.9% limit.
Figure 10.6 depicts the percentage of incident HD
patients by ﬁrst access used, stratiﬁed by time between
date of ﬁrst access formation attempt and HD initiation.
Data from patients incident to dialysis in 2015 and 2016
are included. Longer duration between ﬁrst attempt at
forming dialysis access and ﬁrst HD session was associ-
ated with greater levels of AVF/AVG use at initiation.
Amongst patients for whom the ﬁrst attempt at forming
dialysis access was made more than one year before start-
ing HD, 86.3% initiated with AVF/AVG; whereas for
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Fig. 10.3. Incident RRT ﬁrst access method for patients in the 2016 Multisite Dialysis Access Audit, stratiﬁed by renal centre
Centre size in brackets. Centres are stratiﬁed by transplanting/non-transplanting centre and sorted by decreasing proportion of patients initiating RRT
with a HD catheter (TL/NTL). Eight centres were excluded due to missing transplant or vascular access data.
PTx – pre-emptive transplant; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-
tunnelled line; RRT – renal replacement therapy
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Fig. 10.4. RRT approach at three months for late-presenting patients in the 2016 Multisite Dialysis Access Audit
Centres are sorted by increasing proportion of patients with deﬁnitive access (AVF/AVG/PD). Five centres were excluded as they had,5 late presenting
patients and three centres due to missing data on treatment modality at three months
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line; RRT – renal replace-
ment therapy
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Table 10.4. Modality at start of dialysis and access in use for patients in the 2016 Multisite Dialysis Access Audit, by early and late
presentation at dialysis initiation, by centre, including surgical referral rates within three months before start of dialysis
Centre
Early presenters
(590 days before start of dialysis)
Late presenters
(,90 days before start of dialysis)
Surgical
assessment (%)
Treatment at start
(%)
N PD %
AVF/
AVG% TL %
NTL
% N PD %
AVF/
AVG% TL %
NTL
% Yes No HD PD PTx
Antrim 31 22.6 35.5 16.1 25.8 7 0.0 0.0 28.6 71.4 68.4 31.6 81.6 18.4 0.0
B Heart 120 38.3 29.2 20.0 12.5 ∗ 0.0 0.0 75.0 25.0 41.9 58.1 59.1 34.8 6.1
B QEH 148 22.3 43.9 31.8 2.0 54 9.3 1.9 85.2 3.7 70.8 29.2 75.2 17.4 7.3
Bangor 20 40.0 40.0 10.0 10.0 ∗ 0.0 0.0 100.0 0.0 72.7 27.3 62.5 33.3 4.2
Basldn 37 35.1 27.0 8.1 29.7 10 0.0 0.0 0.0 100.0 46.0 54.0 68.5 24.1 7.4
Bradfd 75 21.3 26.7 32.0 20.0 10 0.0 0.0 50.0 50.0 46.4 53.6 76.7 17.8 5.6
Brightn 107 25.2 39.3 27.1 8.4 42 4.8 2.4 35.7 57.1 45.3 54.7 75.0 18.1 6.9
Bristol 120 22.5 31.7 35.0 10.8 24 0.0 0.0 54.2 45.8 46.8 53.2 75.8 17.2 7.0
Camb 47 6.4 36.2 55.3 2.1 8 0.0 0.0 100.0 0.0 54.2 45.8
Cardff 128 22.7 47.7 18.0 11.7 20 5.0 0.0 50.0 45.0 66.4 33.6 74.8 18.9 6.3
Carlis 22 45.5 13.6 40.9 0.0 7 0.0 0.0 100.0 0.0 23.3 76.7 58.8 29.4 11.8
Chelms 30 40.0 53.3 3.3 3.3 7 14.3 0.0 42.9 42.9 70.3 29.7 63.2 34.2 2.6
Covnt 71 29.6 26.8 26.8 16.9 20 20.0 5.0 30.0 45.0 68.8 31.3 70.6 24.5 4.9
Derby 65 49.2 38.5 4.6 7.7 13 15.4 15.4 23.1 46.2 32.1 67.9 52.4 40.5 7.1
Donc 45 28.9 44.4 15.6 11.1 11 9.1 0.0 36.4 54.5 51.8 48.2 72.4 24.1 3.4
Dorset 58 22.4 55.2 10.3 12.1 15 0.0 0.0 20.0 80.0 48.0 52.0 79.5 16.7 3.8
Dudley 44 27.3 36.4 18.2 18.2 14 7.1 0.0 0.0 92.9 47.2 52.8 72.6 21.0 6.5
Exeter 113 21.2 42.5 15.9 20.4 36 0.0 0.0 22.2 77.8 36.7 63.3 78.8 15.0 6.3
Hull 76 42.1 38.2 17.1 2.6 12 25.0 8.3 33.3 33.3 60.2 39.8 55.8 36.8 7.4
Ipswi ∗ 25.0 25.0 50.0 0.0 ∗ 33.3 0.0 33.3 33.3 100.0 0.0 70.3 24.3 5.4
L Barts 174 36.8 21.3 31.0 10.9 76 18.4 0.0 38.2 43.4 28.8 71.2 64.4 28.4 7.3
L Guys 117 13.7 29.9 41.0 15.4 27 7.4 3.7 25.9 63.0 46.2 53.8 84.6 12.1 3.4
L Kings 122 32.0 30.3 17.2 20.5 21 19.0 4.8 9.5 66.7 36.8 63.2 66.0 28.1 5.9
L Rfree 184 33.2 25.5 27.2 14.1 30 6.7 3.3 46.7 43.3 49.2 50.8 65.1 27.2 7.8
L West 277 15.5 16.6 53.4 14.4 61 3.3 0.0 52.5 44.3 44.7 55.3 81.2 12.5 6.4
Leeds 99 17.2 43.4 13.1 26.3 33 6.1 3.0 9.1 81.8 44.0 56.0 71.4 11.8 16.8
Leic 188 20.2 34.6 29.8 15.4 42 9.5 4.8 45.2 40.5 50.4 49.6 72.0 16.1 11.9
Liv Ain 40 20.0 42.5 25.0 12.5 10 0.0 20.0 50.0 30.0 61.2 38.8 76.4 14.5 9.1
Liv Roy 70 35.7 28.6 25.7 10.0 5 40.0 40.0 0.0 20.0 57.5 42.5 64.8 29.7 5.5
M RI 133 21.8 27.8 33.1 17.3 37 5.4 0.0 29.7 64.9 38.1 61.9 73.0 16.2 10.8
Middlbr 71 14.1 59.2 9.9 16.9 12 8.3 8.3 25.0 58.3 48.8 51.3 77.4 11.8 10.8
Newc 104 26.9 27.9 34.6 10.6 29 0.0 6.9 72.4 20.7 31.6 68.4 71.9 19.2 8.9
Newry 17 17.6 35.3 0.0 47.1 8 0.0 12.5 0.0 87.5 52.0 48.0 84.6 11.5 3.8
Norwch 64 28.1 42.2 25.0 4.7 26 7.7 0.0 34.6 57.7 31.1 68.9 75.3 21.5 3.2
Nottm 76 34.2 39.5 6.6 19.7 33 3.0 6.1 12.1 78.8 32.1 67.9 65.6 21.6 12.8
Oxford 146 32.2 47.3 15.8 4.8 21 9.5 4.8 66.7 19.0 64.2 35.8 62.6 25.8 11.6
Plymth 41 34.1 41.5 9.8 14.6 17 11.8 0.0 17.6 70.6 6.7 93.3 65.6 25.0 9.4
Ports 111 22.5 50.5 18.0 9.0 45 11.1 17.8 28.9 42.2 51.0 49.0 74.6 15.5 9.8
Prestn 81 24.7 46.9 24.7 3.7 19 0.0 0.0 57.9 42.1 60.4 39.6 72.3 17.9 9.8
Redng 72 36.1 38.9 16.7 8.3 16 6.3 0.0 6.3 87.5 30.7 69.3 61.0 27.0 12.0
Salford 117 29.1 29.9 29.1 12.0 36 13.9 0.0 50.0 36.1 39.1 60.9 61.3 23.1 15.6
Sheff 99 15.2 41.4 36.4 7.1 28 3.6 0.0 57.1 39.3 53.8 46.2 84.7 11.7 3.6
Shrew 46 34.8 39.1 6.5 19.6 31 9.7 0.0 16.1 74.2 47.4 52.6 74.4 24.4 1.3
Stevng 90 14.4 33.3 38.9 13.3 55 1.8 1.8 16.4 80.0 37.2 62.8 81.4 8.7 9.9
Sthend 37 40.5 35.1 13.5 10.8 ∗ 0.0 0.0 0.0 100.0 31.7 68.3 59.1 34.1 6.8
Stoke 99 28.3 47.5 17.2 7.1 15 6.7 0.0 13.3 80.0 61.4 38.6 70.8 24.2 5.0
Sund 68 10.3 36.8 48.5 4.4 12 0.0 0.0 41.7 58.3 36.3 63.8 85.9 8.2 5.9
Swanse 105 16.2 47.6 13.3 22.9 58 1.7 1.7 19.0 77.6 22.7 77.3 86.8 10.8 2.4
Truro 35 8.6 54.3 28.6 8.6 11 0.0 0.0 45.5 54.5 56.5 43.5 89.6 6.3 4.2
Ulster 25 24.0 16.0 40.0 20.0 6 0.0 0.0 0.0 100.0 64.5 35.5 73.5 17.6 8.8
West NI 15 13.3 26.7 46.7 13.3 ∗ 0.0 0.0 33.3 66.7 55.6 44.4 88.9 11.1 0.0
Wirral 49 22.4 36.7 26.5 14.3 13 0.0 0.0 30.8 69.2 46.0 54.0 78.8 16.7 4.5
Wolve 61 31.1 36.1 26.2 6.6 17 0.0 0.0 58.8 41.2 41.1 58.9 73.2 23.2 3.7
Wrexm 39 33.3 35.9 20.5 10.3 5 0.0 0.0 40.0 60.0 55.9 44.1 71.4 26.5 2.0
York 50 32.0 32.0 22.0 14.0 18 5.6 0.0 16.7 77.8 36.8 63.2 68.9 23.0 8.1
Total 4,483 25.7 35.6 26.1 12.6 1,198 6.8 2.8 36.2 54.2 45.9 54.1 72.3 20.0 7.6
For a small number of centres the proportion of missing data for presentation date was high, therefore the total number of patients will not be the sum of the
early and late presenting patients.
Blank cells – Cambridge did not submit PTx data, therefore percentage by treatment at start not known
∗fewer than ﬁve patients reported
PTx – pre-emptive transplant; HD -– haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line.
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Table 10.5. Modality at three months after start of dialysis and access in use for patients in the 2016 Multisite Dialysis Access
Audit, by early and late presentation at dialysis initiation, by centre
Early presenters
(590 days before start of dialysis) %
Late presenters
(,90 days before start of dialysis) % Treatment modality at 3 months (%)
Centre Tx PD
AVF/
AVG TL NTL Other Miss
Total
(N) Tx PD
AVF/
AVG TL NTL Other Miss
Total
(N) Tx PD
AVF/
AVG TL NTL Other Miss
Antrim 0.0 22.6 35.5 35.5 0.0 6.5 0.0 31 0.0 0.0 0.0 85.7 0.0 14.3 0.0 7 0.0 18.4 28.9 44.7 0.0 7.9 0.0
B Heart 0.8 43.3 25.8 23.3 0.8 5.8 0.0 120 0.0 0.0 25.0 75.0 0.0 0.0 0.0 ∗ 0.8 41.9 25.8 25.0 0.8 5.6 0.0
B QEH 0.7 24.3 41.9 27.7 0.0 5.4 0.0 148 0.0 9.3 1.9 77.8 1.9 9.3 0.0 54 0.5 20.3 31.2 41.1 0.5 6.4 0.0
Bangor 0.0 40.0 40.0 20.0 0.0 0.0 0.0 20 0.0 0.0 0.0 100.0 0.0 0.0 0.0 ∗ 0.0 34.8 34.8 30.4 0.0 0.0 0.0
Basldn 0.0 35.1 29.7 24.3 0.0 10.8 0.0 37 0.0 10.0 0.0 70.0 0.0 20.0 0.0 10 0.0 28.0 24.0 32.0 0.0 16.0 0.0
Bradfd 1.3 18.7 26.7 49.3 0.0 4.0 0.0 75 0.0 0.0 0.0 70.0 0.0 30.0 0.0 10 1.2 16.5 23.5 51.8 0.0 7.1 0.0
Brightn 0.0 24.3 31.8 33.6 0.0 10.3 0.0 107 0.0 2.4 4.8 64.3 0.0 28.6 0.0 42 0.0 18.1 24.2 42.3 0.0 15.4 0.0
Bristol 4.2 17.5 30.0 45.0 0.0 3.3 0.0 120 0.0 8.3 4.2 83.3 0.0 4.2 0.0 24 3.4 15.8 26.0 51.4 0.0 3.4 0.0
Camb 0.0 8.5 46.8 40.4 0.0 4.3 0.0 47 0.0 0.0 12.5 87.5 0.0 0.0 0.0 8 0.0 5.6 48.6 43.1 0.0 2.8 0.0
Cardff 0.8 21.9 45.3 28.1 0.0 3.9 0.0 128 0.0 5.0 10.0 75.0 0.0 10.0 0.0 20 0.7 19.5 40.3 34.9 0.0 4.7 0.0
Carlis 0.0 50.0 13.6 31.8 0.0 4.5 0.0 22 0.0 14.3 14.3 42.9 0.0 28.6 0.0 7 0.0 40.0 13.3 33.3 0.0 13.3 0.0
Chelms 0.0 40.0 46.7 13.3 0.0 0.0 0.0 30 0.0 14.3 14.3 71.4 0.0 0.0 0.0 7 0.0 35.1 40.5 24.3 0.0 0.0 0.0
Covnt 1.4 18.3 25.4 16.9 1.4 4.2 32.4 71 0.0 20.0 0.0 25.0 0.0 20.0 35.0 20 1.0 17.5 21.6 17.5 1.0 9.3 32.0
Derby 1.5 47.7 35.4 13.8 0.0 1.5 0.0 65 0.0 7.7 23.1 61.5 0.0 7.7 0.0 13 1.3 41.0 33.3 21.8 0.0 2.6 0.0
Donc 2.2 26.7 37.8 28.9 0.0 4.4 0.0 45 0.0 9.1 0.0 81.8 0.0 9.1 0.0 11 1.8 23.2 30.4 39.3 0.0 5.4 0.0
Dorset 1.7 22.4 53.4 10.3 0.0 12.1 0.0 58 0.0 13.3 6.7 53.3 0.0 26.7 0.0 15 1.3 20.0 45.3 18.7 0.0 14.7 0.0
Dudley 2.3 31.8 34.1 22.7 0.0 9.1 0.0 44 0.0 7.1 7.1 7.1 0.0 78.6 0.0 14 1.7 25.9 27.6 19.0 0.0 25.9 0.0
Exeter 0.0 21.2 44.2 23.9 0.9 9.7 0.0 113 0.0 2.8 19.4 33.3 5.6 38.9 0.0 36 0.0 16.7 38.0 26.7 2.0 16.7 0.0
Hull 3.9 32.9 27.6 30.3 0.0 5.3 0.0 76 0.0 16.7 16.7 66.7 0.0 0.0 0.0 12 3.4 30.7 26.1 35.2 0.0 4.5 0.0
Ipswi 0.0 25.0 25.0 50.0 0.0 0.0 0.0 ∗ 0.0 33.3 0.0 66.7 0.0 0.0 0.0 ∗ 2.9 25.7 14.3 48.6 0.0 8.6 0.0
L Barts 1.7 32.2 21.8 39.7 0.6 4.0 0.0 174 0.0 21.1 0.0 61.8 2.6 14.5 0.0 76 1.2 28.2 14.9 47.5 1.2 7.1 0.0
L Guys 5.1 12.8 31.6 50.4 0.0 0.0 0.0 117 0.0 7.4 3.7 70.4 0.0 18.5 0.0 27 4.2 11.8 26.4 54.2 0.0 3.5 0.0
L Kings 0.8 27.0 27.0 40.2 0.0 4.9 0.0 122 0.0 38.1 4.8 57.1 0.0 0.0 0.0 21 0.7 28.5 23.6 42.4 0.0 4.9 0.0
L Rfree 0.5 34.2 29.3 27.7 0.0 8.2 0.0 184 0.0 6.7 3.3 70.0 0.0 20.0 0.0 30 0.5 30.4 25.7 33.6 0.0 9.8 0.0
L West 0.7 14.8 18.4 64.3 0.0 1.8 0.0 277 0.0 3.3 0.0 95.1 0.0 1.6 0.0 61 0.6 12.7 15.1 69.8 0.0 1.8 0.0
Leeds 2.0 19.2 44.4 28.3 0.0 6.1 0.0 99 0.0 12.1 3.0 66.7 3.0 15.2 0.0 33 1.5 17.2 33.6 38.8 0.7 8.2 0.0
Leic 4.3 15.4 28.7 42.0 0.0 9.6 0.0 188 0.0 14.3 4.8 69.0 0.0 11.9 0.0 42 3.5 15.2 24.3 47.0 0.0 10.0 0.0
Liv Ain 0.0 22.5 45.0 25.0 0.0 7.5 0.0 40 0.0 0.0 20.0 50.0 0.0 30.0 0.0 10 0.0 18.0 40.0 30.0 0.0 12.0 0.0
Liv Roy 0.0 32.9 0.0 1.4 0.0 0.0 65.7 70 0.0 40.0 0.0 0.0 0.0 0.0 60.0 5 0.0 29.1 0.0 1.2 0.0 0.0 69.8
M RI 2.3 17.3 27.1 43.6 0.0 9.8 0.0 133 0.0 10.8 0.0 67.6 0.0 21.6 0.0 37 1.6 15.9 19.8 47.8 0.0 14.8 0.0
Middlbr 0.0 8.5 60.6 23.9 0.0 7.0 0.0 71 0.0 8.3 16.7 75.0 0.0 0.0 0.0 12 0.0 8.4 54.2 31.3 0.0 6.0 0.0
Newc 1.9 26.9 26.9 33.7 1.9 8.7 0.0 104 0.0 3.4 6.9 34.5 0.0 55.2 0.0 29 1.5 21.8 22.6 33.8 1.5 18.8 0.0
Newry 0.0 11.8 47.1 35.3 0.0 5.9 0.0 17 12.5 25.0 0.0 37.5 12.5 12.5 0.0 8 4.0 16.0 32.0 36.0 4.0 8.0 0.0
Norwch 1.6 29.7 40.6 23.4 0.0 4.7 0.0 64 0.0 7.7 3.8 73.1 0.0 15.4 0.0 26 1.1 23.3 30.0 37.8 0.0 7.8 0.0
Nottm 3.9 32.9 36.8 23.7 0.0 2.6 0.0 76 0.0 9.1 9.1 30.3 0.0 51.5 0.0 33 2.8 25.7 28.4 25.7 0.0 17.4 0.0
Oxford 2.1 29.5 41.1 22.6 0.0 4.8 0.0 146 0.0 9.5 9.5 76.2 0.0 4.8 0.0 21 1.8 26.8 36.9 29.8 0.0 4.8 0.0
Plymth 0.0 29.3 39.0 14.6 2.4 14.6 0.0 41 0.0 23.5 5.9 23.5 0.0 47.1 0.0 17 0.0 27.6 29.3 17.2 1.7 24.1 0.0
Ports 2.7 25.2 44.1 20.7 0.0 7.2 0.0 111 0.0 15.6 20.0 46.7 0.0 17.8 0.0 45 1.7 20.7 33.9 29.3 0.0 14.4 0.0
Prestn 1.2 19.8 42.0 32.1 0.0 4.9 0.0 81 0.0 5.3 0.0 73.7 5.3 15.8 0.0 19 1.0 16.8 33.7 40.6 1.0 6.9 0.0
Redng 5.6 31.9 33.3 22.2 0.0 6.9 0.0 72 0.0 18.8 0.0 37.5 0.0 43.8 0.0 16 4.5 29.5 27.3 25.0 0.0 13.6 0.0
Salford 3.4 29.9 33.3 29.1 0.0 4.3 0.0 117 0.0 19.4 2.8 52.8 0.0 25.0 0.0 36 3.2 28.7 25.5 33.8 0.0 8.9 0.0
Sheff 1.0 13.1 38.4 42.4 0.0 5.1 0.0 99 0.0 3.6 0.0 85.7 0.0 10.7 0.0 28 0.8 10.6 30.3 52.3 0.0 6.1 0.0
Shrew 0.0 34.8 39.1 10.9 2.2 13.0 0.0 46 0.0 12.9 0.0 29.0 0.0 58.1 0.0 31 0.0 26.0 23.4 18.2 1.3 31.2 0.0
Stevng 1.1 13.3 30.0 51.1 0.0 4.4 0.0 90 0.0 5.5 1.8 58.2 0.0 34.5 0.0 55 0.7 10.3 19.3 53.8 0.0 15.9 0.0
Sthend 0.0 40.5 37.8 18.9 0.0 2.7 0.0 37 0.0 0.0 0.0 50.0 0.0 50.0 0.0 ∗ 0.0 36.6 34.1 22.0 0.0 7.3 0.0
Stoke 0.0 29.3 44.4 21.2 0.0 5.1 0.0 99 0.0 13.3 0.0 60.0 0.0 20.0 6.7 15 0.0 27.2 38.6 26.3 0.0 7.0 0.9
Sund 1.5 4.4 45.6 45.6 1.5 1.5 0.0 68 0.0 0.0 8.3 83.3 8.3 0.0 0.0 12 1.3 3.8 40.0 51.3 2.5 1.3 0.0
Swanse 0.0 20.0 45.7 17.1 2.9 14.3 0.0 105 0.0 3.4 1.7 44.8 0.0 50.0 0.0 58 0.0 14.1 30.1 27.0 1.8 27.0 0.0
Truro 2.9 5.7 57.1 25.7 0.0 8.6 0.0 35 0.0 0.0 0.0 54.5 0.0 45.5 0.0 11 2.2 4.3 43.5 32.6 0.0 17.4 0.0
Ulster 0.0 20.0 20.0 52.0 0.0 8.0 0.0 25 0.0 0.0 0.0 16.7 0.0 83.3 0.0 6 0.0 16.1 16.1 45.2 0.0 22.6 0.0
West NI 0.0 13.3 20.0 60.0 0.0 6.7 0.0 15 0.0 0.0 0.0 100.0 0.0 0.0 0.0 ∗ 0.0 11.1 16.7 66.7 0.0 5.6 0.0
Wirral 0.0 16.3 34.7 38.8 0.0 10.2 0.0 49 0.0 0.0 0.0 61.5 0.0 38.5 0.0 13 0.0 12.7 28.6 42.9 0.0 15.9 0.0
Wolve 0.0 26.2 42.6 21.3 0.0 9.8 0.0 61 0.0 0.0 0.0 35.3 0.0 64.7 0.0 17 0.0 20.3 32.9 25.3 0.0 21.5 0.0
Wrexm 0.0 30.8 38.5 23.1 0.0 7.7 0.0 39 0.0 0.0 0.0 80.0 0.0 20.0 0.0 5 0.0 25.0 31.3 31.3 0.0 12.5 0.0
York 2.0 30.0 28.0 34.0 2.0 4.0 0.0 50 0.0 27.8 5.6 50.0 5.6 11.1 0.0 18 1.5 29.4 22.1 38.2 2.9 5.9 0.0
Total 1.3 25.0 35.2 30.5 0.3 6.0 1.8 4,483 0.2 9.8 5.3 59.6 0.8 22.4 1.8 1,198 1.2 20.9 27.7 38.2 0.4 9.9 1.6
Other is made up from the following categories: withdrew, conservative care, died, transferred out and recovered
∗ – fewer than ﬁve patients reported
Tx – transplant; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line; Miss – missing data
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those patients for whom the ﬁrst attempt at forming
dialysis access was made ,90 days before starting
dialysis, 24.8% commenced HD with an AVF/AVG.
The biggest increment in deﬁnitive dialysis access
occurred between ,90 and 590 days. The data ﬁeld
used for this analysis did not specify which access was
attempted, so it cannot be assumed that ﬁrst access
attempt and access used on ﬁrst session were the same.
Missing data had a similar distribution of access use to
those patients for whom access was ﬁrst attempted within
90 days of initiating dialysis. This pattern differs from
previous years, which may be explained by much higher
data completeness.
Variations in prevalent dialysis access by renal centre
Figure 10.7 provides a funnel plot of the percentage of
prevalent dialysis patients receiving PD or HD via an
AVF/AVG. Seventeen centres met the Renal Associa-
tion audit standard of 580% for deﬁnitive access use
(thick dotted line). Fifteen centres were below the
99.9% limit.
Table 10.6. Dialysis access at three months since dialysis start for patients in the 2016 Multisite Dialysis Access Audit, stratiﬁed by
ﬁrst access used
Access in use at
ﬁrst dialysis (N)
Access in use at three months (%)
AVF/AVG TL NTL PD catheter Transplanted Died Stopped/LTFU No data
AVF/AVG (1,658) 86.9 5.5 0.1 0.2 1.1 3.5 1.1 1.6
TL (1,648) 7.5 78.7 0.2 2.5 1.0 7.0 0.9 2.2
NTL (1,258) 3.5 60.3 1.3 5.7 0.3 25.2 1.7 1.9
PD catheter (1,246) 0.2 5.9 0.2 88.3 2.6 1.8 0.5 0.4
Shaded cells highlight the percentage of patients who remained on the same modality at three months
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line; LTFU –
lost to follow-up
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Fig. 10.6. Percentage of incident HD
patients by ﬁrst access used in the 2016
Multisite Dialysis Access Audit stratiﬁed
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Number of patients in each category in brackets.
Late-presenting patients were excluded from this
analysis. Four centres were excluded due to .50%
missing data for date of ﬁrst access attempt.
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Figure 10.8 depicts dialysis access for prevalent
patients by centre. Wide practice variation is apparent.
Rates of deﬁnitive access ranged between .90% (Liver-
pool Royal) and,50% (LondonWest, Southend, Ulster).
PD accounted for between .25% (Carlisle) and ,5%
(Stevenage) of prevalent deﬁnitive access use.
Peritoneal dialysis audit one-year follow-up by
renal centre
Figure 10.9 shows RRT modality one year after com-
mencing PD by centre. Data for this analysis came
from the 2016 one-year follow-up for patients incident
to dialysis in 2015. Centres with 100% missing data at
one year, or fewer than ﬁve PD patients were excluded.
The percentage of patients remaining on PD or who
were transplanted one year after initiation ranged
between 46.0% (Wolverhampton) and .90.0% (Antrim,
Newry) with an overall mean of 70.7%.
Figure 10.10 depicts PD catheter insertion technique
stratiﬁed by centre. Four centres reporting fewer than
ﬁve patients on PD were excluded from this analysis.
Surgical techniques include open and laparoscopic.
Non-surgical techniques include percutaneous and
peritoneoscopic insertion. There was considerable prac-
tice variation. Twenty-three centres reported use of
non-surgical PD catheter placement, accounting for
35.3% of all catheters placed and 17 of these centres
placed .50% of their PD catheters this way. Five placed
.90% of their PD catheters percutaneously (Birmingham
Heartlands, Southend, Derby, London Kings, Preston).
At the 23 centres that placed non-surgical PD catheters,
22.0% of incident RRT patients started PD, compared
with 20.0% overall. Twenty-seven percent of incident
RRT patients started PD at the six centres that placed
.90% of their catheters percutaneously.
Figure 10.11 displays PD catheter insertion technique
by referral time. There does not appear to be a strong
relationship between referral time and technique used
for PD catheter insertion. This suggests that the PD
access referral pathway may be less dependent on timely
referral than the vascular access pathway.
Figure 10.12 presents the percentage of incident PD
patients by catheter insertion technique and BMI
group. Associations between BMI and PD catheter inser-
tion technique do not appear to be strong and apart from
peritoneoscopic insertion (which was used infrequently
overall) every approach was used for people in each
BMI group, with a slight tendency to less frequent use
of non-surgical techniques at the extremes of BMI.
Patients with missing BMI data had much higher rates
of percutaneous tube insertion (56.6%) than patients
with BMI data.
Figure 10.13 shows a funnel plot of the percentage of
PD catheter failures within one year of initiating dialysis.
Data are from the one-year PD follow-up audit of
patients incident to PD in 2015. PD catheter failure was
censored for transplantation, elective transfer to HD or
death. Of the 31 centres for which data were available,
one was above the 95% limit for PD catheter failure
with a catheter failure rate of 59.3%. Seven centres were
below the lower 99.9% limit, only one of which reported
any failed PD catheters. The mean one-year catheter
failure rate was 18.4% (13.3% in 2015). Only 13 cases
of peritonitis were reported within two weeks of catheter
insertion in 2016, but data completeness was too low
(20.8%) to permit a reliable estimate of early peritonitis
rates.
Figure 10.14 shows comparative access failures by
access type within three months of initiating dialysis.
Data were drawn from the 2015 and 2016 Multisite
Dialysis Access Audits. Access failure was deﬁned as a
documented date of failure/discontinuation recorded
within three months of starting dialysis, unless a centre
comment indicated that it was a planned discontinuation.
Failure rates appeared marginally higher for PD than for
HD access. Numbers of AVGs and peritoneoscopically
inserted PD tubes were very low, hence the wide conﬁ-
dence intervals (CIs) for these data, which overlap with
the failure rates of all other access techniques.
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Fig. 10.7. Funnel plot of the percentage of prevalent patients in
the 2016 Multisite Dialysis Access Audit receiving PD or HD via
AVF/AVG
Thick dotted line = 80% Renal Association audit standard. A total of 14
centre-level exclusions were made for this analysis due to non-completion
of prevalent dialysis access data and .10% differences between centre-
reported and UKRR numbers of patients receiving dialysis
HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft
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Fig. 10.8. Prevalent dialysis access by centre for patients in the 2016 Multisite Dialysis Access Audit
Centre size in brackets. Centres are sorted by decreasing proportion of patients initiating RRT with a HD catheter. Fourteen centre-level exclusions were
made due to non-completion of prevalent dialysis access data and.10% differences between centre-reported and UKRR numbers of patients receiving
dialysis
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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Figure 10.15 shows cause of catheter failure within one
year of initiating dialysis for the 166 failed PD catheters
reported in the one-year PD follow-up audit (patients
incident to dialysis in 2015). The small number of failed
catheters increases the likelihood that differences in cause
of failure between subgroups were due to chance. Patients
undergoing surgical and non-surgical PD catheter inser-
tion were also likely to differ in ways that inﬂuenced the
likelihood of catheter failure.
Discussion
This audit shows, once again, that rates of deﬁnitive
dialysis access amongst both incident and prevalent
patients were below Renal Association audit standards.
A small number of centres achieved high rates of deﬁni-
tive dialysis access for incident and prevalent dialysis
recipients, demonstrating that the audit standards are
attainable.
Several factors have recurrently been shown to associ-
ate with deﬁnitive dialysis access. Timely presentation to
a nephrologist and referral to a dialysis access surgeon
were associated with higher rates of deﬁnitive dialysis
access use. Most patients who only meet a nephrologist
for the ﬁrst time within three months of starting dialysis
commenced HD via a NTL/TL. However, a substantial
proportion of patients known to a nephrologist for
more than three months also commenced HD via a
NTL/TL, and indeed conversion from a NTL/TL to
deﬁnitive access by three months was infrequent in
most centres. One in four individuals who initiated
dialysis with a NTL died within three months. The con-
tributions of acute renal pathology, comorbid illness
and access complications to these deaths cannot be quan-
tiﬁed with these data.
The need to begin access planning early is conﬁrmed
by the observation that most individuals who had access
attempted more than a year before initiating HD started
with an AVF/AVG. A small number of centres secured
deﬁnitive access within three months for late-presenting
patients, achieved for most through PD. No clinical prac-
tice guideline exists to drive rapid placement of deﬁnitive
access amongst late presenting individuals, but centres
achieving this have, by deﬁnition, responsive dialysis
access pathways. Most commonly, responsive PD access
pathways were achieved using a predominantly percuta-
neous rather than surgical catheter insertion approach.
This is logical, since this is generally performed under
local anaesthetic, avoiding the requirement for both a
pre-operative assessment and operating theatre time.
An increasing number of centres were performing per-
cutaneous catheter insertion. Some centres were able to
achieve surgical vascular access for a substantial propor-
tion of late-presenting patients. Efforts to better under-
stand practice patterns that enhance the responsiveness
of vascular and PD access services are needed. Results
from the UK Peritoneal Dialysis Outcomes and Practice
Patterns Study (PDOPPS) Catheter Study are awaited
[3]. A national survey of HD access in the UK by the
British Renal Society Vascular Access Special Interest
Group showed that the infrastructure to support delivery
of quality vascular access is in place in most centres [4].
This would suggest that there are other factors that
determine how effectively patterns of practice can achieve
successful outcomes. Further work to improve
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Fig. 10.9. Modality at one year after commencing PD in 2015,
by centre
Number of patients receiving PD at each centre in brackets. Centres with
100% missing treatment data at one year (12 centres) or fewer than ﬁve
PD patients (one centre) were excluded. Centres are sorted by decreasing
proportion of patients transplanted or remaining on PD
PD – peritoneal dialysis; HD – haemodialysis; Tx – transplanted; None –
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Fig. 10.10. PD catheter insertion technique (surgical vs non-surgical) stratiﬁed by centre for patients in the 2016 Multisite Dialysis
Access Audit
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compliance with Renal Association standards is highly
recommended.
It has been suggested that lower rates of deﬁnitive
dialysis access in some centres may be a result of higher
rates of PTx because transplanted patients may otherwise
have started dialysis with deﬁnitive access. This hypoth-
esis is not supported by the data presented.
The UKRR has an important role in monitoring the
quality of planned and unplanned RRT provision and
informing guidance and practice improvement. Wide
variation in practice reﬂects the absence of a cohesive
approach, despite national guidance. The insights gained
from the inclusion of information about all three RRT
modalities in this chapter reﬂect the importance of a
comprehensive approach in the exploration of trends in
RRT access provision. Once again, this year’s Multisite
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Dialysis Access Audit identiﬁes the need for an improved
understanding of what drives heterogeneity in access
practice along with approaches to standardise and
enhance care.
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